InnerVision was founded in 2002 with a mandate to improve healthcare through 'world-changing' biomedical diagnosis tools. This is to be achieved with breakthrough acoustic technology, and a business model that is simultaneously cost effective for the health care system, and profitable for InnerVision.

InnerVision Medical Technologies Inc. is a privately held technology company engaged in the research, development and eventual commercialization of an ultra high resolution, instant-capture, acoustic based imaging system. This technology is called Flash Ultrasound™. We believe Flash Ultrasound™ is a significant scientific breakthrough which combines novel techniques in acoustic wave analysis and the computational power of new age super computing.

The system is initially being developed for the screening diagnosis of breast cancer and prostate cancer as well as imaging applications in pharmaceutical research and development.

To date, InnerVision has focused on scientific research, filing associated patents, and assembling management expertise and financial resources to support and steward commercialization of its diagnostic imaging technology.

InnerVision's Board and Management are the principle investors in the company, and are stewarding InnerVision towards commercializing its technology. InnerVision's scientific leaders, technical team and scientific and medical advisors are dedicated to ongoing innovation in diagnostic imaging.